|
LMBRD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.836380E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.762400E-04 |
| Normal-vs-Stage2 |
8.342800E-01 |
| Normal-vs-Stage3 |
1.373020E-01 |
| Normal-vs-Stage4 |
2.712100E-02 |
| Stage1-vs-Stage2 |
4.424000E-02 |
| Stage1-vs-Stage3 |
9.951600E-02 |
| Stage1-vs-Stage4 |
6.145600E-01 |
| Stage2-vs-Stage3 |
4.164800E-01 |
| Stage2-vs-Stage4 |
1.793390E-01 |
| Stage3-vs-Stage4 |
3.980800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.384300E-03 |
| Normal-vs-AfricanAmerican |
4.918200E-03 |
| Normal-vs-Asian |
2.558700E-04 |
| Caucasian-vs-AfricanAmerican |
1.166840E-01 |
| Caucasian-vs-Asian |
6.340000E-02 |
| AfricanAmerican-vs-Asian |
8.531800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.248370E-01 |
| Normal-vs-Female |
6.846500E-04 |
| Male-vs-Female |
1.168160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.010000E-04 |
| Normal-vs-Age(41-60Yrs) |
3.618900E-03 |
| Normal-vs-Age(61-80Yrs) |
9.496400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.630400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.353400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.939330E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.230200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.302470E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.585000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.574200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.482600E-01 |
| Classical-VS-Follicular |
1.217750E-04 |
| Classical-VS-Other |
3.159800E-01 |
| Classical-VS-Normal |
1.69600999999631E-05 |
| Tall-VS-Follicular |
4.766400E-02 |
| Tall-VS-Other |
5.964200E-01 |
| Tall-VS-Normal |
5.744200E-02 |
| Follicular-VS-Other |
6.561400E-01 |
| Follicular-VS-Normal |
6.047200E-01 |
| Other-VS-Normal |
7.767400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.742300E-02 |
| Normal-vs-N1 |
5.557800E-02 |
| N0-vs-N1 |
4.789800E-01 |
|
|
